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Abstract—We explored the potential of health screening based 
on the long-term measurement of cardiovascular parameters 
using the finger volume-oscillometric technique. An automated 
instrument made simultaneous measurements of key 
cardiovascular parameters, including blood pressure, pulse 
pressure, heart rate, normalized pulse volume as an index of 
α-adrenalin-mediated sympathetic activity, and finger arterial 
elasticity. These were derived from finger photo- 
plethysmographic signals during application of cuff pressure. To 
assess the feasibility of achieving a screening function, 
measurements were made in ten healthy volunteers during 10 
days of day-to-day living (normal condition), and carried out 
several times at a fixed time every day. During successive 10-day 
measurements, a 30-hour period of total sleep deprivation was 
introduced as a physiological challenge (abnormal condition). A 
linear discriminant analysis of the data was conducted to 
determine whether these two conditions could be discriminated. 
Periodic data collection was performed rapidly and easily, and 
the %-correct classifications of normal and abnormal conditions 
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were 78.2% and 77.5%, respectively. This ability of the method 
to discriminate between regular and sleep-deprived activities 
demonstrates its potential for healthcare screening during 
day-to-day living. Further investigations using larger age and 
gender groups of subjects including patients with cardiovascular 
diseases under real-life situations are required. 
 
Index Terms—blood pressure, finger-artery elasticity index, 
pulse pressure, heart rate, normalized pulse volume, healthcare. 
 
I. INTRODUCTION 
CADEMIC researchers and device companies are now 
actively developing compact, low-cost technologies for 
convenient and effective health screening, monitoring and 
personalized healthcare [1]–[3]. A recognized goal is to 
produce devices and the associated processing, transmission 
and data analysis tools capable of being integrated into the 
normal daily lives of millions of citizens across the world. 
Such technologies are being developed to allow for the early 
detection and therapeutic monitoring of infections, 
inflammatory and malignant diseases, and cardiovascular, 
neurological and metabolic disorders. Specific developments 
include point-of-care blood analyzers [4], point-of-care testing 
of physiological variables using a smartphone [1], [2], body 
area sensor networks [5] and non-intrusive physiological 
monitoring instruments [6], [7]. In all cases the roles of 
information technologies are critical. 
Of relevance to this major medical and societal problem are 
the continued advances in the monitoring and diagnostic 
technologies that allow physiological measurements in 
ambulatory subjects and during normal daily life [1], [8]–[11]. 
These advances could be used to develop health screening 
instrumentation. It is therefore pertinent and timely to consider 
how such measurement technologies may be further developed 
and applied to achieve convenient screening for personalized 
healthcare. 
We have previously described the design of a compact and 
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convenient instrument, which accurately (compared to the 
conventinal method) and precisely (reproducibly) measures 
certain cardiovascular indices with established methods [12]. 
Briefly, measurements are taken from a single finger, using 
photo-plethysmography for the detection of peripheral pulse 
volume signals. The instrument then calculates: 1) systolic, 
mean and diastolic blood pressure (SBP, MBP and DBP, 
respectively) using the volume-oscillometric method [13] 
–[15]; 2) pulse pressure (PP), which is a strong predictor of 
increased large artery stiffness and high cardiovascular risk 
[16]; 3) heart rate (HR); 4) normalized pulse volume (NPV), 
which reflects !-adrenalin-mediated sympathetic control of the 
finger arteriolar vessels [17], [18]; and 5) the finger-artery 
elasticity index (FEI) derived from a simple descriptive model 
of the exponential pressure-volume function for the finger 
vascular bed [17], [19], modified by the volume elastic 
modulus [20]. 
These cardiovascular indices are simultaneously obtained 
using the present instrument and, whilst each is of interest and 
significant in itself, the adoption of a comprehensive method 
for handling the combined datasets is necessary if they are to 
be of practical use. For example, the detection of 
measurements falling outside of their normal range, followed 
by a sequence of appropriate actions should be achieved 
automatically by efficient processing, transmission and storage 
technologies. The development of such systems to achieve a 
screening function that might lead in the long term to 
improvements in health-related disorders is a significant aim 
of our on-going studies. Meanwhile, the screening method for 
heart diseases and sleep apnea syndrome using a single 
physiological index, e.g., blood pressure or heart rate 
variability, has been reported [21]–[23]. However, to the best 
of our knowledge, there are no published studies concerning a 
comprehensive method for handling combined multiple 
physiological variables, and such studies are desirable to 
screen for some specific health conditions, including 
cardiovascular abnormalities, at an early stage through general 
daily healthcare. Therefore, we describe here an early pilot 
assessment of a simplified method for discriminating between 
regular and irregular daily activities in healthy young male 
volunteers, performed over 10-day periods, firstly during 
normal daily living and secondly with the imposition of a 
30-hr period of sleep deprivation as a physiological challenge 
intended to create some cardiovascular effects. Discriminant 
analysis is then used to determine whether the method could 
distinguish between normal and abnormal health conditions. 
 
II. MATERIALS AND METHODS 
A. System Description 
Fig. 1 shows an outline of the prototype system for the 
measurement of BP, PP, HR, NPV and FEI, part of which was 
reported in a preliminary publication in Japanese [12]. Briefly, 
the developed system comprises two main units [see Fig. 
1(a)]: 1) a control unit (laptop computer, vostro1200; Dell 
Inc.; Kawasaki; Japan); 2) a measuring unit [268W " 78H1 
(37H2) " 184D mm] comprising a finger cuff with a 
cylindrical jig (#35 " 54H mm), a near-infrared light emitting 
diode (LED: SMC810; peak emission wavelength 810 nm; 
Epitex Inc.; Kyoto; Japan) as a light source and a photo diode 
(PD: BPW34FAS; OSRAM GmbH; Munich; Germany) as a 
detector, an air pump, a pressure sensor and associated 
components. In the measuring unit, the LED is driven in a 
pulsatile mode at a frequency of 300 Hz [see circuit block 
diagram, Fig 1(b)]. The signal from the photodiode detector is 
 
 
Fig. 1. Outline of the prototype system (a), and schematic block diagram of the measuring unit (b). BP = blood pressure, HR = heart rate, lnNPV = ln 
normalized pulse volume, FEI = finger-artery elasticity index, PPG = photo-plethysmogram, PGdc = direct-current component of PPG, PGac = 
alternating-current component of PPG, Pc = cuff pressure, LED = light emitting diode, PD = photo diode. 




first amplified by a pre-amplifier and then conditioned to 
subtract ambient light. The resulting signal constitutes the 
photo-plethysmogram (PPG), comprising of a direct-current 
(dc) component (PGdc) and an alternating-current (ac) 
component (PGac), the latter representing the pulsatile arterial 
blood volume, or pulse. The dc and ac components of the PPG 
are further amplified. The ac amplifier has a bandpass 
frequency characteristic of 1–20 Hz (–3 dB). The analogue 
signals PGdc and PGac, together with a signal representing the 
cuff pressure (Pc) are sampled at a frequency of 100 Hz with a 
resolution of 12 bits and sent to the the digital data then sent to 
the control unit via a USB2.0 connection. The signals are 
subsequently displayed in real-time and calculations based on 
the principles of each measurement are carried out using 
LabVIEW2009 software (National Instruments Japan Corp., 
Tokyo, Japan). 
The measurement process, which is started with a serial 
command from the control unit, has two phases, as shown in 
Fig. 2. Firstly, Pc is maintained at 30 mmHg for 10-s to 
measure the NPV and HR (see Step 1 in Fig. 2); secondly, 
whilst applying a gradual change (5 mmHg/s) in 
counter-pressure, the BP, PP and FEI are measured by 
application of the volume-oscillometric procedure (see Step 2 
in Fig. 2). 
B. Measurement Principle 
Normalized pulse volume (NPV), shown to be a valid index 
of α-adrenalin-mediated sympathetic activity [18], [24], was 
calculated on a beat-by-beat basis by dividing the PGac by 
PGdc on the condition that the counter-pressure is constant [17], 
[18], [24], giving the following equation: 
                              NPV = PGac PGdc  (1) 
In this study, after applying a logarithmic transformation to 
standardize the distribution, the lnNPV was averaged over 
10-s. Heart rate (HR) was derived from the peak-to-peak 
intervals of the PGac signal for the same duration as for the 
NPV measurement. This NPV value obtained with the current 
instrument constitute reference data in itself, because we 
applied the established methods in our present instrument. 
Systolic and mean blood pressure (SBP and MBP, 
respectively) were measured from the right index finger artery 
using the volume-oscillometric method [13]–[15]. The 
volume-oscillometric method is based on the nonlinear nature 
of the pressure-volume characteristics in the artery. When 
applying a gradual change in counter-pressure externally to 
the anatomical segment, characteristic changes in the 
amplitude of arterial volume pulsations produced by the pulse 
pressure are observed due to the arterial tube law [14], [15]. 
The determination of SBP and MBP by this method is given as 
the Pc values corresponding to the systolic end point and the 
point of maximum amplitude of volume pulsation, 
respectively (see Fig. 2). Diastolic blood pressure (DBP) 
cannot be obtained by this method, but it can be calculated 
from the SBP and MBP determined above along with the 
volume determinant factor measured from the volume 
pulsation waveform [25]. Pulse pressure (PP) is calculated by 
subtracting DBP from SBP. This finger volume-oscillometric 
method has previously been clinically validated against direct 
(Oxford) and conventional upper arm-cuff methods using 
normotensive and hypertensive subjects [26], [27]. In addition, 
we have already compared BP values obtained with the 
present instrument to those obtained with the conventional 
upper arm-cuff method in a previous report (in Japanese) [12]. 
According to these results, the fixed bias and precision of SBP, 
MBP and DBP derived from Bland-Altman plots of data from 
the developed system and the upper arm-cuff method averaged, 
with a mean ± standard deviation (data n = 625), −5.4 ± 7.0 
mmHg, −2.5 ± 9.0 mmHg and −1.1 ± 9.7 mmHg, respectively. 
These results clearly indicated that BP in the finger artery 
could be measured with acceptable accuracy using the present 
instrument. 
Finger-artery elasticity index (FEI), shown to be a valid 
index of finger vascular elasticity [17], [19], and measured by 
the volume-oscillometric procedure mentioned above, was 
defined as the absolute value of the slope that follows the 
curvilinearity in the pressure-volume function of the finger 
artery, and can be calculated from the linear relationship of the 
log-transformed compliance index (CI: = NPV/PP) to the 




Fig. 2. Typical recordings of applied cuff pressure (Pc), 
photo-plethysmographic pulsation signal (PGac & PGdc), and calculated 
beat-by-beat lnNPV. SBP = systolic blood pressure, MBP = mean blood 
pressure, PP = pulse pressure, HR = heart rate, lnNPV = ln normalized 
pulse volume, FEI = finger-artery elasticity index, MAP = point of 
maximum amplitude, SEP = systolic end point. 




                             FEI = d (lnCI ) dPtr  (2) 
This FEI value obtained with the current instrument 
constitute reference data in itself, because we applied the 
established methods in our present instrument. 
C. Experimental Method 
1) Participants: Ten healthy young male participants, with a 
mean ± standard deviation age, height, weight and body mass 
index of 21.8 ± 0.8 years, 169.9 ± 4.0 cm, 59.0 ± 6.5 kg and 
20.4 ± 1.6, respectively, and no known cardiovascular 
disorders participated in the preliminary study. All subjects 
agreed to take part in the study voluntarily and signed an 
informed consent statement. The study was approved by the 
ethics commission of the Faculty of Medicine of Kanazawa 
University, and was performed in accordance with the ethical 
standards laid down in the 1964 Declaration of Helsinki and 
its later amendments. 
2) Apparatus: The experiment was conducted in a quiet 
experimental room at a temperature of approximately 25°C, 
which was constructed at Kanazawa University. A desk and a 
comfortable chair for participants to sit on were made 
available in this room. The prototype was placed on the right 
side of the participant and kept at heart level. 
3) Experimental Design: The study had an ABA (A: regular 
activity, B: irregular activity) design. The participants were 
asked to maintain their regular daily routines and 
sleeping/waking hours from at least 2 days before 
commencement of the experiment, and continuing for the 
10-day experimental (ABA) period, which included a 3-day 
rest period immediately after the B-period to avoid the 
possibility of influencing the following A-period. 
A-period: The participants were requested to sit down on 
the seat. One-shot measurements (maximum 1-min) were 
made after a 3-min rest period and were repeated throughout 
the morning, afternoon and early-evening during the 
experimental period (3 times/day) for every participant, and 
were always made a significant time before main meals. 
B-period: The participants were asked to undergo a 30-hr 
period of total sleep deprivation, from day 3 through day 4, as 
a physiological challenge. The reason for applying this sleep 
deprivation challenge was to create physiological responses 
and it was anticipated that the cardiovascular variables 
simultaneously obtained from the present instrument would 
reflect such responses. During, and only during, this 
 
 
Fig. 3. Typical recordings of systolic, mean and diastolic blood pressure (SBP, MBP and DBP), pulse pressure (PP), heart rate (HR), log-transformed 
normalized pulse volume (lnNPV), and finger-artery elasticity index (FEI) measured by the prototype system, the visual analogue scale (VAS) of fatigue 
and sleepiness, and self-reported sleep time during day-to-day living (a); and recordings of an expanded time-scale during sleep deprivation (b). 




awakening B-period, using a prepared timetable referred to as 
Vaara’s method [28], the measurement was iteratively carried 
out every 3-hr from day 3 at 10:00 to day 4 at 16:00. In 
addition, the participants completed a questionnaire for the 
subjective rating of fatigue and sleepiness using a visual 
analogue scale (VAS; [29]) for every measurement. 
4) Data Reduction and Analyses: To evaluate whether or not 
our system has the potential to screen for adverse effects on 
health, a linear discriminant analysis using the cardiovascular 
indices was conducted. We used MBP as a representative BP 
value in this analysis. We classified the collected data as after 
sleep deprivation and baseline; we defined sleep deprivation 
as the data gathered on day 4 at 07:00 (20-hr), 10:00 (24-hr), 
13:00 (27-hr) and 16:00 (30-hr). Baseline is the rest of the data 
except for the balance of data during the 30-hr of total sleep 
deprivation. In addition, a linear discriminant analysis was 
conducted for total data. To exclude individual differences in 
the absolute value, the delta change (Δ) in reactivity was 
calculated by subtracting averaged baseline values at 10:00 
from each value. The analysis was carried out using IBM 
SPSS Statistics 21 for Windows (IBM Inc., Tokyo, Japan). 
 
III. RESULTS 
Fig. 3(a) is a typical example of a 10-day trend chart from 
one subject, showing SBP, MBP, DBP, PP, HR, lnNPV and 
FEI together with VAS data for fatigue and sleepiness, and the 
self-reported sleep time. Fig. 3(b) shows an expanded 
time-scale during the sleep deprivation period. The prototype 
instrument allowed the periodic collection of physiological 
data without any failed measurements. It can be seen that the 
variables changed depending on the physical status as judged 
by the VAS. In particular, it was clearly demonstrated that the 
BP, HR and lnNPV values varied during the period of 30-hr 
sleep deprivation as compared with the values during the rest 
period. 
We classified the dataset into baseline and sleep deprivation 
groups [see the top of Fig. 3(a)]. Table I shows the summary 
of the linear discriminant analysis for all subjects combined. 
The classification function and its results are shown in the left 
and right parts, respectively. Based on the p-values, the 
effective indices for discrimination were found to be HR (F1, 
254 = 55.48, p < 0.01), lnNPV (F1, 254 = 18.32, p < 0.01) and 
FEI (F1, 254 = 7.73, p < 0.01). The %-correct classifications of 
baseline (i.e., specificity) and sleep deprivation (i.e., 
sensitivity) were 78.2% and 77.5%, respectively, and 
the %-correct predictions of baseline (i.e., negative predictive 
value) and sleep deprivation (i.e., positive predictive value) 
were 95.0% and 39.2%, respectively. 
IV. DISCUSSION 
A simplified method ultimately intended for health 
screening, based on the non-invasive simultaneous 
measurement of SBP, MBP, DBP, PP, HR, NPV and FEI 
using a finger cuff, was found to perform reliably in 
preliminary tests with ten healthy young male volunteers over 
10 days of normal day-to-day living. The method was found to 
be able to discriminate between the normal status and an 
abnormal condition created by a 30-hr period of total sleep 
deprivation. 
It has been reported that 30-hr sleep deprivation changes 
adjustments in the autonomic regulation of the heart, i.e., it 
decreases heart rate [30], [31]. Taking the effective indices 
obtained here into consideration, our findings are consistent 
with these reports. A decrease in lnNPV, representing 
peripheral vasoconstriction, could imply compensatory 
behavior to regulate BP in response to a drop in HR. Such 
physiological reactions are plausible. Thus, the percentages of 
TABLE I 
SUMMARY OF LINEAR DISCRIMINANT ANALYSIS IN ALL SUBJECTS 
 
Linear discriminant function 
 
Result 
Indices Coefficient Standardized coefficient F1, 254 p-value  
Predicted %-Correct 
classification Baseline Sleep deprivation 


















PP -0.0063 -0.0712 0.34 n.s. 


















lnNPV 0.0339 0.5574 18.32 <.01 
















Constant 0.2676 - - - 95.0% 39.2% 
Note. MBP = mean blood pressure, PP = pulse pressure, HR = heart rate, lnNPV = ln normalized pulse volume, FEI = finger-artery elasticity index. 




correctly classified samples (baseline: 78.2%, sleep 
deprivation: 77.5%) might be considered to be highly 
satisfactory. 
The cardiovascular variables we used in the analysis were 
MBP, PP, HR, lnNPV and FEI, which were the key variables 
obtained from this prototype instrument. It has been reported 
that the FEI reflects structural (not functional) changes in the 
finger artery [17], [19], and the PP is also known to change 
with age following the progressive stiffening of larger arteries 
[16]. For these reasons, FEI and PP are generally recognized 
as long-term cardiovascular risk factors. Concerning FEI, our 
present results show that this index was effective for 
discriminating between normal and the imposed acute sleep 
deprivation condition, as shown in Table I. This is, in fact, 
inconsistent with the previous findings mentioned above. 
Although a definite reason for this is not yet clear, one 
possibility could be considered. According to Tanaka et al.’s 
measurement procedure [19], FEI is calculated from the 
average value of eight or nine measurements. Therefore, the 
one-shot measurement applied in the present prototype might 
be inadequate to evaluate the long-term elasticity of small 
arteries. However, if we use day-to-day values in an 
appropriate database, we could estimate the long-term finger 
artery stiffness by calculating the moving-average of these 
accumulated data. As for the PP measurements in our present 
results, these were found to be ineffective indices for 
discriminating between the normal and the sleep deprivation 
conditions. Although this result was to be expected in the 
present study, it is probably more appropriate to process the 
data in the same way as for FEI. In any case, it seems 
reasonable to speculate that our system, by using the measured 
FEI and PP individually, might be able to screen for the 
development of cardiovascular diseases if data collected over 
the medium to long term are used for the discriminant 
analysis; this needs to be validated adequately by recruiting 
patients with cardiovascular diseases in a future study. 
By contrast, abnormalities of health occurring in the 
short-term, e.g., events of acute stress, will particularly be 
predicted by the BP, HR and/or lnNPV indices, as 
demonstrated here in the sleep deprivation example. Naturally, 
the indices that act as effective predictors of abnormality will 
be different for different health conditions, e.g., physical 
and/or mental exhaustion, degradation of general health with 
aging, or a cardiac disease. It is likely that there will also be 
differences in the most effective predictor among individuals 
for any given health condition. Methodological development 
to achieve the most appropriate discriminant function for each 
condition and the associated information and communication 
technology to create a complete health screening system is 
therefore required. To achieve this, further investigations will 
be needed in larger age and gender groups of subjects with a 
variety of health conditions under real-life situations to 
develop and test the system for health screening. 
Further physiological variables could be added in our 
system, and we are investigating blood constituent 
measurements, e.g., the levels of blood glucose, albumin, 
cholesterol and alcohol, using multiple wavelength 
photo-plethysmography to assist with general daily healthcare. 
This work is still in its infancy [32]–[35], but future progress 
is expected, and these are targets to be integrated eventually 
into our system. In connection with this, blood alcohol 
measurement using the optical principle is interesting and 
significant. Our method is intended to be a simpler technique 
that could lead to the development of instrumentation for use 
by motor vehicle drivers in order to reduce health and alcohol 
related motor vehicle accidents as novel vehicle safety locks. 
This was an early pilot trial and there were therefore several 
possible limitations. Firstly, only ten healthy young men 
participated in the study. Studies with larger groups, with a 
wider age range, including both male and female subjects and 
patients (e.g., with cardiovascular disease), need to be carried 
out. Secondly, in this first pilot study we used the sleep 
deprivation challenge to simulate an abnormal health 
condition in the laboratory environment and it will now be 
necessary to examine a variety of common health conditions 
under real-life constraints in order to test the suitability of this 
method for health screening more comprehensively. Finally, 
we only used discrete-time measurements of cardiac 
phenomena for acute stress in this preliminary study. Monthly 
or yearly long-term monitoring, if possible by applying 
chronic stress, in healthy participants or outpatients with 
cardiovascular diseases should be conducted in a future study. 
In this manner, many technical, theoretical and experimental 
challenges still need to be overcome in order to improve the 
prevention and treatment of cardiovascular diseases that may 
be caused by the events of chronic and acute stress. The 
preliminary trial of our simplified method with a prototype 
instrument in healthy young adults could open up new 
possibilities for the design of convenient systems for 
cardiovascular health screening. 
 
V. CONCLUSION 
A simplified method for health screening based on 
non-invasive cardiovascular measurements from just one 
finger using the volume-oscillometric technique and its 
preliminary assessment are described. Assessment of the 
method for screening regular and irregular daily activities 
using the cardiovascular parameters was conducted for ten 
healthy volunteers during 10 days of day-to-day living. The 
method was able to discriminate between the normal status 
and an abnormal condition created by a 30-hr period of total 
sleep deprivation as a physiological challenge. This ability of 
the method to discriminate between regular and sleep-deprived 
activities demonstrates its potential for healthcare screening 
during day-to-day living. Further investigations using larger 
age and gender groups of subjects including patients with 
cardiovascular diseases under real-life situations are required. 
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